APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study
Embracing the setting sun: Provision of palliative care via a collaborative model between hospital and community for patients with intellectual disabilities
Supportive care and symptom management in patients with advanced hematological malignancies: a literature review
Perspective of palliative care in radiation-oncology
Combination therapy with low-dose metolazone and furosemide: a "needleless" approach in managing refractory fluid overload in elderly renal failure patients under palliative care
Intensive Palliative Care for Patients With Hematological Cancer Dying in Hospice: Analysis of the Level of Medical Care in the Final Week of Life
End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia
Bringing palliative care into geriatrics in a Chinese Culture Society - Results of a collaborative model between palliative medicine and geriatrics unit in Hong Kong
The first confirmed case of human avian influenza A(H7N9) in Hong Kong and the suspension of volunteer services: Impact on palliative care
Symptom burden, depression, and suicidality in chinese elderly patients suffering from advanced cancer
Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients
Quality of life for Hong Kong chinese patients with advanced gynecological cancers in the palliative phase of care: A cross-sectional study
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Rational design of a booster vaccine against COVID-19 based on antigenic distance
The trends in lung cancer prevalence, incidence, and survival in Hong Kong over the past two decades (2002–2021): a population-based study
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study
Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC